InvestorsHub Logo
Followers 4
Posts 682
Boards Moderated 0
Alias Born 06/26/2013

Re: None

Friday, 05/01/2020 3:46:34 PM

Friday, May 01, 2020 3:46:34 PM

Post# of 30990
I have no idea why MYMD is hiding behind the "updating" curtain, but it may be that they are looking to demonstrate the effectiveness of their MYMD-1 against Hashimoto's Thyroiditis on persons identified with the disease in Phase 2 FDA trials. With that in hand they probably would be free to license major pharmaceutical companies in the areas listed in the previous message.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.